Status:
COMPLETED
Specified Drug Use-results Survey (Long-term Use) on MINIRINMELT® OD Tablet (Nocturia)
Lead Sponsor:
Ferring Pharmaceuticals
Conditions:
Nocturia Due to Nocturnal Polyuria
Eligibility:
MALE
18+ years
Brief Summary
To investigate the incidence and risk factors of desmopressin-induced hyponatremia during long-term treatment (1 year \[52 weeks\]) of MINIRINMELT orally disintegrating (OD) tablets 25μg/50μg (drug) f...
Eligibility Criteria
Inclusion
- Participants who received the MINIRINMELT for the first time in men with nocturia due to nocturnal polyuria, an indication for drug.
Exclusion
- No exclusion criteria defined for this study.
Key Trial Info
Start Date :
May 19 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 25 2024
Estimated Enrollment :
1087 Patients enrolled
Trial Details
Trial ID
NCT04329975
Start Date
May 19 2020
End Date
September 25 2024
Last Update
December 20 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Survey Site (there may be other sites in this country)
Tokyo, Japan